switching back to semaglutide from tirzepatide If semaglutide does not work
Description
A dedicated single-injection 7.2 mg pen is expected later in 2026
This slightly gentler absorption curve from the thigh may actually explain the lower nausea rate found in clinical research
While these are typically only relevant in diagnostic settings, any drug affecting pituitary function or hormone levels could theoretically impact sermorelin therapy
The glucagon receptor can cause nausea through a different pathway than GLP-1, meaning some people experience a qualitatively different type of nausea than what they felt on tirzepatide
